Keywords
Pulmonary Arterial Hypertension ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

47 Search results.

Eligibility Sleep Disorders in Pulmonary Arterial Hypertension NCT01371669 - Eligibility Sleep Disorders in Pulmonary Arterial HypertensionNCT01371669

- 9/28/20 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Screening for Sleep Hypoxemia in Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01371669

Eligibility Life Change Events NCT02284737

- 6/28/20 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT02284737

Eligibility Suspected Arterial Hypertension NCT01278732

- 4/19/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass; ODM derived from: https://clinicaltrials.gov/show/NCT01278732

Eligibility Idiopathic Pulmonary Arterial Hypertension. NCT02108743

- 4/16/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT02108743

Eligibility Idiopathic Pulmonary Arterial Hypertension NCT01884051

- 4/16/20 - 1 form, 2 itemgroups, 25 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Hormonal, Metabolic, and Signaling Interactions in PAH; ODM derived from: https://clinicaltrials.gov/show/NCT01884051

Eligibility Idiopathic Pulmonary Arterial Hypertension NCT01246037

- 4/15/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Beta-blockers in i-PAH; ODM derived from: https://clinicaltrials.gov/show/NCT01246037

Eligibility Idiopathic Pulmonary Arterial Hypertension NCT01590108

- 4/15/20 - 1 form, 1 itemgroup, 16 items, 1 language
Itemgroup: Criteria
The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01590108

Eligibility Idiopathic Pulmonary Arterial Hypertension NCT01645826

- 4/15/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01645826

Eligibility Pulmonary Artery Hypertension NCT01581086

- 2/19/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Vascular Subphenotypes of Lung Disease in HIV & COPD; ODM derived from: https://clinicaltrials.gov/show/NCT01581086

Eligibility Pulmonary Arterial Hypertension NCT02516722

- 6/26/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
TReatment Of Pulmonary HYpertension 1 Study; ODM derived from: https://clinicaltrials.gov/show/NCT02516722

Eligibility Pulmonary Arterial Hypertension NCT02080533

- 6/25/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT02080533

Eligibility Pulmonary Arterial Hypertension NCT02032836

- 6/25/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparative PK PD Study in PAH Patients (Fox vs. I-Neb); ODM derived from: https://clinicaltrials.gov/show/NCT02032836